Letter: now is the time to remove complexity from HCV guidelines to ensure that elimination remains a priority

Aliment Pharmacol Ther. 2020 Sep;52(6):1096-1097. doi: 10.1111/apt.15978.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Aminoisobutyric Acids
  • Benzimidazoles
  • Cyclopropanes
  • Hepatitis C, Chronic* / drug therapy
  • Hepatitis C, Chronic* / epidemiology
  • Humans
  • Lactams, Macrocyclic
  • Leucine / analogs & derivatives
  • Proline / analogs & derivatives
  • Pyrrolidines
  • Quinoxalines
  • Sulfonamides

Substances

  • Aminoisobutyric Acids
  • Benzimidazoles
  • Cyclopropanes
  • Lactams, Macrocyclic
  • Pyrrolidines
  • Quinoxalines
  • Sulfonamides
  • pibrentasvir
  • Proline
  • Leucine
  • glecaprevir